211 related articles for article (PubMed ID: 31595620)
21. Inappropriate sinus tachycardia - successful treatment with ivabradine.
Celebi OO; Canbay A; Celebi S; Aydogdu S; Diker E
Kardiol Pol; 2010 Aug; 68(8):935-7. PubMed ID: 20730728
[TBL] [Abstract][Full Text] [Related]
22. Initiation of ivabradine in cardiogenic shock.
Chiu MH; Howlett JG; Sharma NC
ESC Heart Fail; 2019 Oct; 6(5):1088-1091. PubMed ID: 31332966
[TBL] [Abstract][Full Text] [Related]
23. [Inappropriate sinus tachycardia - ailment or disease?].
Ptaszyński P; Kaczmarek K; Poddębska I; Cygankiewicz I
Kardiol Pol; 2013; 71(10):1087-9. PubMed ID: 24197593
[TBL] [Abstract][Full Text] [Related]
24. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of medical and ablation therapy for inappropriate sinus tachycardia: A single-center experience.
Shabtaie SA; Witt CM; Asirvatham SJ
J Cardiovasc Electrophysiol; 2021 Apr; 32(4):1053-1061. PubMed ID: 33566447
[TBL] [Abstract][Full Text] [Related]
26. Inappropriate sinus tachycardia: a review.
Ali M; Haji AQ; Kichloo A; Grubb BP; Kanjwal K
Rev Cardiovasc Med; 2021 Dec; 22(4):1331-1339. PubMed ID: 34957774
[TBL] [Abstract][Full Text] [Related]
27. Effects of Heart Rate Reduction With Either Pyridostigmine or Ivabradine in Patients With Heart Failure: A Randomized, Double-Blind Study.
Villacorta AS; Villacorta H; Caldas JA; Precht BC; Porto PB; Rodrigues LU; Neves M; Xavier AR; Kanaan S; Mesquita CT; da Nóbrega ACL
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):139-145. PubMed ID: 30198318
[TBL] [Abstract][Full Text] [Related]
28. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
29. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.
Rivinius R; Helmschrott M; Rahm AK; Darche FF; Thomas D; Bruckner T; Doesch AO; Katus HA; Ehlermann P
Clin Res Cardiol; 2022 Feb; 111(2):141-153. PubMed ID: 32572551
[TBL] [Abstract][Full Text] [Related]
30. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
Rivinius R; Helmschrott M; Ruhparwar A; Rahm AK; Darche FF; Thomas D; Bruckner T; Ehlermann P; Katus HA; Doesch AO
Clin Res Cardiol; 2018 Feb; 107(2):138-147. PubMed ID: 29098378
[TBL] [Abstract][Full Text] [Related]
31. Ivabradine in Cardiovascular Disease Management Revisited: a Review.
Chen C; Kaur G; Mehta PK; Morrone D; Godoy LC; Bangalore S; Sidhu MS
Cardiovasc Drugs Ther; 2021 Oct; 35(5):1045-1056. PubMed ID: 33411112
[TBL] [Abstract][Full Text] [Related]
32. Ivabradine for inappropriate sinus tachycardia-induced symptomatic Mobitz type I atrio-ventricular block: a case summary.
Korolewicz J; Meenakshisundaram R; Lim PB
Eur Heart J Case Rep; 2023 Jun; 7(6):ytad192. PubMed ID: 37360007
[TBL] [Abstract][Full Text] [Related]
33. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
[TBL] [Abstract][Full Text] [Related]
34. The use of ivabradine in a patient with inappropriate sinus tachycardia and cardiomyopathy due to limb girdle muscular dystrophy type 2I.
Rajendram R; AlDhahri F; Mahmood N; Kharal M
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31969397
[TBL] [Abstract][Full Text] [Related]
35. Ivabradine in the treatment of non-paroxysmal junctional tachycardia with interference atrioventricular dissociation: A case report.
Ying S; Zhang J; Fu NK; Zhang P
Ann Noninvasive Electrocardiol; 2023 Jul; 28(4):e13064. PubMed ID: 37157886
[TBL] [Abstract][Full Text] [Related]
36. Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine.
Sağ S; Çoşkun H; Baran İ; Güllülü S; Aydınlar A
Anatol J Cardiol; 2016 Mar; 16(3):212-3. PubMed ID: 27067557
[No Abstract] [Full Text] [Related]
37. [Inappropriate sinus tachycardia].
Sossalla S; Vollmann D
Dtsch Med Wochenschr; 2015 Apr; 140(8):603-7. PubMed ID: 25945910
[TBL] [Abstract][Full Text] [Related]
38. Ivabradine as an Adjunct for Refractory Junctional Ectopic Tachycardia Following Pediatric Cardiac Surgery: A Preliminary Study.
Kumar V; Kumar G; Tiwari N; Joshi S; Sharma V; Ramamurthy R
World J Pediatr Congenit Heart Surg; 2019 Nov; 10(6):709-714. PubMed ID: 31701840
[TBL] [Abstract][Full Text] [Related]
39. Clinical presentation of inappropriate sinus tachycardia and differential diagnosis.
Peyrol M; Lévy S
J Interv Card Electrophysiol; 2016 Jun; 46(1):33-41. PubMed ID: 26329720
[TBL] [Abstract][Full Text] [Related]
40. Management of inappropriate sinus tachycardia with ivabradine in a renal transplant recipient.
Kumar Goyal V; Godara S; Chandra Sadasukhi T; Lal Gupta H
Drug Discov Ther; 2014 Jun; 8(3):132-3. PubMed ID: 25031045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
